The Effect of Lavender Oil Applied Via Inhalation on Headache and Anxiety Level
1 other identifier
interventional
62
1 country
1
Brief Summary
This randomized controlled study aims to determine the effect of pure lavender oil inhalation on headache severity and anxiety levels in hemodialysis (HD) patients. The research, conducted in three dialysis centers, included a total of 62 patients who were randomly assigned to either an intervention group (n=30) receiving lavender oil inhalation or a control group (n=32) receiving standard care. Data were collected using the Visual Analogue Scale (VAS) for headache severity and the State-Trait Anxiety Inventory (STAI) for anxiety levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2019
CompletedFirst Submitted
Initial submission to the registry
September 22, 2025
CompletedFirst Posted
Study publicly available on registry
December 23, 2025
CompletedDecember 23, 2025
December 1, 2025
2 months
September 22, 2025
December 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Headache Severity measured by Visual Analog Scale (VAS).
Headache severity is measured using a 10-unit Visual Analog Scale (VAS) where "0" represents no pain and "10" represents the most severe pain possible. A lower score indicates a reduction in headache intensity
Measured 3 times during each hemodialysis session (immediately before, 2 hours after start, and at the end of dialysis) over a period of 4 weeks (total of 12 sessions).
Secondary Outcomes (2)
State Anxiety Levels measured by State Anxiety Inventory (STAI-S).
Measured at the 2nd and 4th hours of dialysis sessions throughout the 4-week study period.
Trait Anxiety Level (STAI-T)
At the beginning of the study (baseline) and at the end of the 4th week.
Study Arms (2)
Pure Lavender Oil Inhalation Group
OTHERParticipants assigned to the lavender oil inhalation intervention.
Control group patients.
OTHERA total of 32 control group patients (standard hemodialysis care)
Interventions
Participants receive pure medical lavender oil (Lavandula angustifolia) with a certificate of analysis. During the 2nd hour of the dialysis session, 3 drops of lavender oil are applied to a 6x6 cm gauze pad. Patients are instructed to inhale the scent from a distance of 5 cm for 5 minutes. This procedure is performed 3 times a week for 4 weeks, totaling 12 sessions. The dosage adjustment and application are performed by the researchers.
Participants in the control group receive only routine hemodialysis treatment. No additional aromatherapeutic intervention or inhalation is administered during the study period.
Eligibility Criteria
You may qualify if:
- Those who are 18 years of age and over,
- Able to understand and communicate in Turkish,
- Receiving hemodialysis treatment three times a week for at least 3 months,
- Not pregnant and not planning a pregnancy,
- Having a pain intensity of 3 or more on the Visual Analog Scale, measured twice,
- Headache that develops during dialysis,
- Headache worsening throughout the dialysis session,
- Headache resolves spontaneously within 72 hours after dialysis ends,
- No visual or hearing impairment,
- Individuals who could take painkillers when they had pain were included in the study
You may not qualify if:
- Those who are allergic to or uncomfortable with the smell of lavender oil,
- Having any obstacle to smell,
- Having a history of asthma,
- Individuals who used other complementary integrative medicine methods during the treatment process were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erciyes Univercity
Kayseri, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Phd
Study Record Dates
First Submitted
September 22, 2025
First Posted
December 23, 2025
Study Start
December 1, 2018
Primary Completion
January 30, 2019
Study Completion
August 30, 2019
Last Updated
December 23, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Beginning 6 months after publication of the study results, and will be available for 10 years.
- Access Criteria
- The data will be available upon request by contacting the corresponding author via email. The requester must sign a data access agreement.
Deidentified individual participant data (IPD) will be shared. Supporting documents such as the study protocol and clinical study report will also be available